| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.2 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.2 | 0.2 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.037 | 0.2 |